Structure of mammalian trefoil factors and functional insights.

[1]  F. May,et al.  Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. , 2005, Biochemistry.

[2]  M. Pera,et al.  Trefoil factor family peptide 3 prevents the development and promotes healing of ischemia-reperfusion injury in weanling rats. , 2004, Journal of pediatric surgery.

[3]  F. May,et al.  The trefoil protein TFF1 is bound to MUC5AC in humangastric mucosa , 2004, Cellular and Molecular Life Sciences.

[4]  R. Shaoul,et al.  Colonic Expression of MUC2, MUC5AC, and TFF1 in Inflammatory Bowel Disease in Children , 2004, Journal of pediatric gastroenterology and nutrition.

[5]  Richard O'Kennedy,et al.  Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Feeney,et al.  Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. , 2003, Biochemistry.

[7]  S. Major,et al.  The closely related estrogen-regulated trefoil proteins TFF1 and TFF3 have markedly different hydrodynamic properties, overall charge, and distribution of surface charge. , 2003, Biochemistry.

[8]  I. Gipson,et al.  Role of mucins in the function of the corneal and conjunctival epithelia. , 2003, International review of cytology.

[9]  L. Thim,et al.  Effect of trefoil factors on the viscoelastic properties of mucus gels , 2002, European journal of clinical investigation.

[10]  J. Dekker,et al.  Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. , 2002, Human pathology.

[11]  Sara J. Prest,et al.  The estrogen‐regulated protein, TFF1, stimulates migration of human breast cancer cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  T. Wang,et al.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. , 2002, The Journal of clinical investigation.

[13]  Carr,et al.  High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factors , 2001 .

[14]  J. Newton,et al.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice , 2001, Gut.

[15]  Mark A. Williams,et al.  The solution structure of the disulphide‐linked homodimer of the human trefoil protein TFF1 , 2001, FEBS letters.

[16]  L. Thim,et al.  Human pS2/trefoil factor 1: production and characterization in Pichia pastoris. , 2001, Protein expression and purification.

[17]  R. Poulsom,et al.  Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa , 2000, Gut.

[18]  H. S. Kim,et al.  Somatic mutations of the trefoil factor family 1 gene in gastric cancer. , 2000, Gastroenterology.

[19]  J. Newton,et al.  The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach , 2000, Gut.

[20]  J. Newton,et al.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach , 2000, Gut.

[21]  C. Tomasetto,et al.  pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. , 2000, Gastroenterology.

[22]  S. Poulsen,et al.  Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat , 1999, Gut.

[23]  R. Playford,et al.  The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS , 1999, The Journal of pathology.

[24]  R. Playford,et al.  Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects , 1998, The Journal of pathology.

[25]  F. May,et al.  Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. , 1997, The Biochemical journal.

[26]  F. May,et al.  Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells , 1997, The Journal of pathology.

[27]  T. Frenkiel,et al.  High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. , 1997, Journal of molecular biology.

[28]  M. Fishman,et al.  Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.

[29]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[30]  H. Kataoka,et al.  cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. , 1996, The Biochemical journal.

[31]  M. Carr,et al.  NMR-based structural studies of the pNR-2/pS2 single domain trefoil peptide. Similarities to porcine spasmolytic peptide and evidence for a monomeric structure. , 1995, European journal of biochemistry.

[32]  G. Jirikowski,et al.  Molecular and cellular analysis of rP1.B in the rat hypothalamus: in situ hybridization and immunohistochemistry of a new P-domain neuropeptide. , 1995, Brain research. Molecular brain research.

[33]  H. Itoh,et al.  Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. , 1995, The Biochemical journal.

[34]  L. Thim,et al.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. , 1995, Gastroenterology.

[35]  F. May,et al.  Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58. , 1995, The Biochemical journal.

[36]  M. Fishman,et al.  Structure and expression of murine intestinal trefoil factor: high evolutionary conservation and postnatal expression. , 1995, Biochemical and biophysical research communications.

[37]  R. Ezzell,et al.  Molecular Cloning of the Rat Intestinal Trefoil Factor Gene , 1995, The Journal of Biological Chemistry.

[38]  L. Thim,et al.  Characterization of human and rat intestinal trefoil factor produced in yeast. , 1995, Biochemistry.

[39]  R. Playford,et al.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. , 1995, Gastroenterology.

[40]  L. Thim,et al.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. , 1994, The Journal of clinical investigation.

[41]  M. J. Gradwell,et al.  Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Wang,et al.  Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. , 1994, Gastroenterology.

[43]  P. Freemont,et al.  Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Kim,et al.  Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. , 1994, The Journal of biological chemistry.

[45]  Z. Dauter,et al.  Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. , 1993, Structure.

[46]  R. Poulsom,et al.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Chambon,et al.  The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression , 1993, The Journal of cell biology.

[48]  B. Sands,et al.  Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. , 1993, The Journal of biological chemistry.

[49]  L. Thim,et al.  Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast , 1993, FEBS letters.

[50]  M. Carr,et al.  1H NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of "trefoil" motif containing cell growth factors. , 1992, Biochemistry.

[51]  M. Fujino,et al.  Complete primary structure of the human estrogen-responsive gene (pS2) product. , 1991, Journal of biochemistry.

[52]  R. Lathe,et al.  hSP, the domain‐duplicated homolog of pS2 protein, is co‐expressed with pS2 in stomach but not in breast carcinoma. , 1990, The EMBO journal.

[53]  K. Rose,et al.  Revised amino acid sequence of pancreatic spasmolytic polypeptide exhibits greater similarity with an inducible pS2 peptide found in a human breast cancer cell line. , 1989, Biochimica et biophysica acta.

[54]  L. Thim.  A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins) , 1989, FEBS letters.

[55]  M. Ohta,et al.  Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product. , 1988, Biochemical and biophysical research communications.

[56]  P. Chambon,et al.  [Primary structure of human protein pS2]. , 1988, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[57]  L. Thim,et al.  The amino acid sequence of pancreatic spasmolytic polypeptide. , 1985 .

[58]  M. Le Cunff,et al.  Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. , 1985, DNA.

[59]  P Chambon,et al.  Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. , 1984, Nucleic acids research.

[60]  L. Thim,et al.  The amino acid sequence of pancreatic spasmolytic polypeptide , 1983, Regulatory Peptides.

[61]  L. Thim,et al.  Pancreatic Spasmolytic Polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas , 1982, Regulatory Peptides.